PHOSPHATIDYLINOSITOL (PI) 3-KINASE AND PI 4-KINASE BINDING TO THE CD4-P56(LCK) COMPLEX - THE P56(LCK) SH3 DOMAIN BINDS TO PI 3-KINASE BUT NOT PI 4-KINASE
CD4 serves as a receptor for major histocompatibility complex class II antigens and as a receptor for the human immunodeficiency virus type 1 (HIV-1) viral coat protein gp120. It is coupled to the protein-tyrosine kinase p56lck, an interaction necessary for an optimal response of certain T cells to antigen. In addition to the protein-tyrosine kinase domain, p56lck possesses Src homology 2 and 3 (SH2 and SH3) domains as well as a unique N-terminal region. The mechanism by which p56lck generates intracellular signals is unclear, although it has the potential to interact with various downstream molecules. One such downstream target is the lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase), which has been found to bind to activated pp60src and receptor-tyrosine kinases. In this study, we verified that PI 3-kinase associates with the CD4:p56lck complex as judged by the presence of PI 3-phosphate generated from anti-CD4 immunoprecipitates and detected by high-pressure liquid chromatographic analysis. However, surprisingly, CD4-p56lck was also found to associate with another lipid kinase, phosphatidylinositol 4-kinase (PI 4-kinase). The level of associated PI 4-kinase was generally higher than PI 3-kinase activity. HIV-1 gp120 and antibody-mediated cross-linking induced a 5- to 10-fold increase in the level of CD4-associated PI 4- and PI 3-kinases. The use of glutathione S-transferase fusion proteins carrying Lck-SH2, Lck-SH3, and Lck-SH2/SH3 domains showed PI 3-kinase binding to the SH3 domain of p56lck, an interaction facilitated by the presence of an adjacent SH2 domain. PI 4-kinase bound to neither the SH2 nor the SH3 domain of p56lck. CD4-p56lck contributes PI 3-and PI 4-kinases to the activation process of T cells and may play a role in HIV-1-induced immune defects.
机构:
Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USAScripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USA
Vogt, Peter K.
Gymnopoulos, Marco
论文数: 0引用数: 0
h-index: 0
机构:
Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USAScripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USA
Gymnopoulos, Marco
Hart, Jonathan R.
论文数: 0引用数: 0
h-index: 0
机构:
Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USAScripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA 92037 USA
机构:
Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA
Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USAUniv Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Stjepanovic, Goran
Baskaran, Sulochanadevi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA
Denali Therapeut, San Francisco, CA 94080 USAUniv Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Baskaran, Sulochanadevi
Lin, Mary G.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USAUniv Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Lin, Mary G.
Hurley, James H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA
Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USAUniv Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Zhang, Xuan
Chen, Xingjuan
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Chen, Xingjuan
Jia, Caixia
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Jia, Caixia
Geng, Xian
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Geng, Xian
论文数: 引用数:
h-index:
机构:
Du, Xiaona
Zhang, Hailin
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China